Triggering of Suicidal Erythrocyte Death by Zosuquidar
Triggering of Suicidal Erythrocyte Death by Zosuquidar
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: Cell Physiol Biochem Press GmbH & Co KG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: Cell Physiol Biochem Press GmbH & Co KG
Subjects
More information
Scope and Contents
Contents
Background: The P-glycoprotein inhibitor zosuquidar (LY335979) is clinically used to augment the effect of cytostatic drugs on suicidal tumor cell death or apoptosis. The present study explored whether the substance is cytotoxic to erythrocytes. Upon injury, erythrocytes may undergo suicidal cell death or eryptosis, which is characterized by cell s...
Alternative Titles
Full title
Triggering of Suicidal Erythrocyte Death by Zosuquidar
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_26646161
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_26646161
Other Identifiers
ISSN
1015-8987
E-ISSN
1421-9778
DOI
10.1159/000438589
